Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 125 participants.

Also called NCT02985684

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 125 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02985684
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02985684. Allocation not applicable; no masking; primary purpose treatment. Start 2017-03-10 (actual); primary completion 2018-07-30 (actual). Results posted on 2020-01-07.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs
Acronym
ASSURED
Condition
Atrial Septal Defect
Intervention (Device)
GORE® CARDIOFORM ASD Occluder
Lead sponsor
W.L.Gore & Associates (class: industry)

Record details

Record id
cardio:ct-nct02985684
Content hash
118966790863488d9103cce3e4ff6e256d203e426e2843e4a8b1f0a52d7f62f8